Vascular Graft Market Size, Share, Growth – By Raw Material, By Application, By End Use, Global Forecast, 2025 to 2034

Vascular Graft Market Size

The global vascular graft market size was valued at USD 3.6 billion in 2024 and is expected to exhibit growth at a CAGR of 6.9% from 2025 to 2034 period. The market growth is attributed to the increasing prevalence of cardiovascular diseases, technological advancements, rising incidence of end-stage renal disease (ESRD), and increase in surgical procedures, among other contributing factors.
 

Moreover, the increasing prevalence of cardiovascular diseases, such as atherosclerosis and coronary artery disease, drives the demand for vascular grafts. For instance, according to the World Health Organization (WHO), cardiovascular diseases cause around 17.9 million deaths annually, accounting for 32% of global deaths. These medical conditions frequently require bypass grafting and other surgical procedures. The growing elderly population and lifestyle-related health factors contribute to the higher occurrence of cardiovascular diseases, expanding the need for vascular grafts.
 

Furthermore, innovations such as bioengineered, hybrid, and synthetic vascular grafts have improved graft performance and patient outcomes. These advancements provide enhanced durability and biocompatibility. Additionally, the rise of minimally invasive procedures has made vascular surgeries safer and more accessible, boosting market growth.
 

Vascular graft is a medical device used to replace, repair, or bypass damaged blood vessels. It can be made from synthetic materials, biological tissues, or a combination of both, and is commonly used in procedures such as coronary artery bypass, intracranial aneurysm repair, and hemodialysis access. Vascular grafts help restore normal blood flow and prevent complications like ischemia or rupture.
 

Vascular Graft Market Trends

The market is experiencing several market trends that are shaping its growth and development. Factors such as increasing adoption of bioengineered and biodegradable grafts, rise of hybrid graft technologies, advancements in 3D printing technology, and increasing preference for minimally invasive procedures, among other factors are boosting the industry growth.
 

• Advanced imaging techniques such as CT scans, MRI, and 3D ultrasound, paired with surgical navigation systems, are improving the precision and outcomes of vascular graft surgeries. These technologies help surgeons visualize blood vessels and graft placement more accurately, reducing errors and complications. The integration of these tools into surgical procedures enhances patient safety and drives the adoption of advanced grafts, contributing to market expansion.
   
• Further, there is a growing trend toward using sustainable and eco-friendly materials in the production of vascular grafts, driven by the global push for environmental responsibility. Manufacturers are exploring biodegradable and recyclable materials that reduce the environmental impact of medical waste. This trend aligns with broader environmental goals and may offer long-term benefits in terms of reducing the ecological footprint of medical devices, thereby aforementioned factors are expected to drive the market.
   

Vascular Graft Market Analysis

Based on raw material, the market is segmented into polyester grafts, EPTFE grafts, biosynthetic grafts, and polyurethane grafts. The Polyester grafts segment is expected to drive business growth and expand at a CAGR of 7.3%, reaching over USD 4.7 billion by 2034.
 

• Polyester grafts, commonly made from materials like Dacron, are highly durable and strong, making them ideal for long-term use in vascular surgeries. Their ability to withstand high pressure from blood flow and their resistance to degradation over time make them a preferred choice for many vascular procedures, particularly for large vessel repairs. This durability increases their adoption in surgeries that require long-lasting solutions.
   
• Additionally, these grafts are known for their biocompatibility, which reduces the risk of immune rejection or severe inflammatory reactions in patients. The material structure promotes good tissue integration, enhancing the healing process. Their relatively low risk of infection, compared to some other graft types, makes them a reliable option in surgical procedures where infection is a major concern.
   

Based on application, the vascular graft market is segmented as endovascular aneurysm repair, hemodialysis access, and peripheral vascular repair. The endovascular aneurysm repair segment further bifurcated into abdominal aortic aneurysm repair and thoracic aortic aneurysm repair. The endovascular aneurysm repair segment is expected to drive business growth and expand at a CAGR of 7.7%, reaching over USD 3.5 billion by 2034.
 

• Endovascular aneurysm repair (EVAR) is a minimally invasive procedure that requires only small incisions, which results in quicker recovery times, reduced hospital stays, and fewer complications compared to traditional open surgery. This has made EVAR the preferred choice for treating aneurysms, especially among elderly and high-risk patients. As a result, the demand for vascular grafts used in EVAR procedures continues to rise.
   
• Moreover, technological advancements in endografts, which are used in EVAR, have improved their design, durability, and biocompatibility. Modern endografts are more flexible, provide better sealing, and reduce the risk of complications such as endoleaks. These innovations enhance the success rates of EVAR procedures, driving the increased adoption of vascular grafts in the market.
   

Based on end use, the vascular graft market is classified into hospitals, ambulatory surgical centers, and other end users. The hospitals segment dominated the market with a revenue share of 62.4% in 2024.
 

• Hospitals are experiencing a steady increase in the number of vascular surgeries due to the growing prevalence of cardiovascular diseases and aneurysms. These surgeries often require the use of vascular grafts for procedures such as bypass surgery, aneurysm repair, and peripheral artery disease treatments. The higher volume of surgeries directly drives the demand for vascular grafts within hospital settings.
   
• Furthermore, hospitals are focused on improving patient care and ensuring better surgical outcomes. Advanced vascular grafts, especially those used in minimally invasive surgeries, contribute to reduced complication rates, quicker recovery times, and better long-term patient outcomes. This shift toward better results and patient satisfaction encourages hospitals to invest in high-quality vascular graft technologies.
   

U.S. vascular graft market accounted for USD 1.1 billion in 2024 and is anticipated to grow at a CAGR of 6.1% between 2025 to 2034 period.
 

• The U.S. is at the forefront of adopting cutting-edge surgical techniques, including minimally invasive procedures such as endovascular aneurysm repair (EVAR). These procedures often require specialized vascular grafts, like stent-grafts, which offer patients quicker recovery and fewer complications. The increased preference for these less invasive techniques is driving the demand for advanced graft solutions in the U.S. healthcare system.
   
• In addition, the country is a hub for innovation in medical technology, and advancements in vascular grafts, such as bioengineered and hybrid grafts, are being developed to improve outcomes for patients undergoing vascular surgeries. These innovations offer better biocompatibility, reduced risk of complications, and improved durability. As hospitals and surgical centers adopt these advanced grafts, the market for vascular grafts continues to expand.
   

Germany vascular graft market is projected to grow remarkably in the coming years.
 

• Germany boasts a well-developed healthcare system with a high standard of medical care and advanced surgical facilities. This strong infrastructure enables the widespread use of vascular grafts for treating a variety of vascular conditions, from aortic aneurysms to peripheral artery disease. The availability of cutting-edge medical equipment and specialized treatment centers contributes to the rising adoption of vascular grafts in the country.
   
• Furthermore, the country’s healthcare system is largely covered by statutory health insurance, which provides reimbursement for vascular surgeries, including those involving grafts. The government’s strong support for healthcare infrastructure and access to treatments increases the affordability and accessibility of vascular surgeries, thereby boosting the demand for grafts. The reimbursement policies facilitate the adoption of advanced graft technologies across the healthcare system.
   

China holds a dominant position in the Asia Pacific vascular graft market.
 

• The aging population of  China is a key driver in the market. The elderly are more prone to developing vascular conditions such as aneurysms and peripheral artery disease, necessitating surgical treatments that require grafts. As the population over 60 continues to grow, there will be an increasing need for grafts in surgeries targeting age-related vascular diseases.
   
• Further, the country is investing heavily in medical device innovation, with numerous local and international companies developing new types of vascular grafts. Research in biomaterials and advanced graft technologies is helping improve the performance and biocompatibility of grafts. These innovations are helping to meet the growing demand for more effective, durable, and minimally invasive solutions in vascular surgery.
   

Vascular Graft Market Share

The market characterized by the presence of both established multinational companies and emerging players focusing on innovation and specialized solutions. Key players such as Medtronic, GORE, and Cook Medical lead the market with their extensive portfolios of polyester, ePTFE, and hybrid grafts. These companies are focusing on technological advancements, such as bioengineered grafts and minimally invasive solutions, to differentiate their offerings. Additionally, the market is becoming increasingly competitive due to the growing demand for personalized treatments, driving companies to invest in R&D and strategic partnerships for new product development.
 

Vascular Graft Market Companies

Prominent players operating in the vascular graft industry include:

• Abbott
• ARTIVION
• B. Braun
• BD (Becton, Dickinson & Company)
• Cook Medical
• Cordis
• Endologix
• GETINGE
• LeMaitre
• Medtronic
• MERIT MEDICAL
• MicroPort
• Terumo
• Vascular Graft Solutions
• GORE
   

Vascular Graft Industry News:

• In August, 2024, Terumo Corporation announced the launch of TREO stent-graft system for endovascular aneurysm repair (EVAR), designed for infrarenal abdominal aortic aneurysms with both suprarenal and infrarenal active fixation. This innovation strengthens Terumo competitive position in the market, allowing it to capitalize on growing demand for advanced, minimally invasive solutions and expand its market share.
   
• In January 2024, W. L. Gore & Associates received FDA approval for its lower-profile GORE VBX Stent Graft, an enhancement to its proven device for treating complex vascular diseases. This approval introduces the longest balloon-expandable stent and the most 6 Fr-compatible configurations available. It strengthens Gore competitive position and is expected to drive growth and increased sales in the vascular sector.
   

The vascular graft market research report includes an in-depth coverage of the industry with estimates and forecast in terms of revenue in USD Million and from 2021 – 2034 for the following segments:

Click here to Buy Section of this Report

Market, By Raw Material

• Polyester grafts
• EPTFE grafts
• Biosynthetic grafts
• Polyurethane grafts

Market, By Application

• Endovascular aneurysm repair
  • Abdominal aortic aneurysm repair
  • Thoracic aortic aneurysm repair
• Hemodialysis access
• Peripheral vascular repair

Market, By End Use

• Hospitals
• Ambulatory surgical centers
• Other end users

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Netherlands
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE